Lifevantage (NASDAQ:LFVN) Shares Cross Below 200 Day Moving Average – Here’s What Happened

Lifevantage Corporation (NASDAQ:LFVN) shares crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $12.61 and traded as low as $8.87. Lifevantage shares last traded at $8.96, with a volume of 90,667 shares trading hands.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the company. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Lifevantage in a report on Wednesday. Wall Street Zen cut Lifevantage from a “buy” rating to a “hold” rating in a research note on Friday, October 3rd. Two equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $30.50.

Lifevantage Price Performance

The stock has a 50 day simple moving average of $11.77 and a two-hundred day simple moving average of $12.61. The company has a market cap of $113.70 million, a PE ratio of 12.11 and a beta of 0.26.

Lifevantage (NASDAQ:LFVN) last released its quarterly earnings results on Thursday, September 4th. The company reported $0.17 EPS for the quarter, hitting the consensus estimate of $0.17. Lifevantage had a return on equity of 33.75% and a net margin of 4.29%.The business had revenue of $55.11 million during the quarter, compared to analysts’ expectations of $57.93 million. During the same quarter in the prior year, the business earned $0.14 earnings per share. Lifevantage has set its FY 2026 guidance at 1.000-1.15 EPS.

Lifevantage Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 16th. Stockholders of record on Monday, September 8th were paid a dividend of $0.045 per share. This represents a $0.18 annualized dividend and a dividend yield of 2.0%. The ex-dividend date was Monday, September 8th. Lifevantage’s dividend payout ratio is 24.32%.

Insider Activity at Lifevantage

In other news, Director Michael A. Beindorff sold 4,125 shares of the company’s stock in a transaction that occurred on Tuesday, September 9th. The stock was sold at an average price of $11.44, for a total transaction of $47,190.00. Following the completion of the sale, the director owned 22,858 shares in the company, valued at $261,495.52. This represents a 15.29% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 21.95% of the stock is owned by company insiders.

Institutional Investors Weigh In On Lifevantage

Several large investors have recently modified their holdings of the stock. Osaic Holdings Inc. raised its stake in shares of Lifevantage by 780.3% during the second quarter. Osaic Holdings Inc. now owns 14,270 shares of the company’s stock worth $187,000 after purchasing an additional 12,649 shares during the last quarter. Squarepoint Ops LLC grew its holdings in Lifevantage by 68.1% during the second quarter. Squarepoint Ops LLC now owns 70,507 shares of the company’s stock worth $922,000 after acquiring an additional 28,574 shares during the period. Evergreen Capital Management LLC acquired a new position in Lifevantage during the second quarter worth $379,000. Wasatch Advisors LP grew its holdings in Lifevantage by 6.6% during the second quarter. Wasatch Advisors LP now owns 446,341 shares of the company’s stock worth $5,838,000 after acquiring an additional 27,765 shares during the period. Finally, Man Group plc grew its holdings in Lifevantage by 72.5% during the second quarter. Man Group plc now owns 53,098 shares of the company’s stock worth $695,000 after acquiring an additional 22,319 shares during the period. Hedge funds and other institutional investors own 35.32% of the company’s stock.

Lifevantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.